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httpIntroduction: Silver-coated grafts are designed to prevent vascular graft infections. Silver is a safe element but
toxic effects have been reported. We describe two cases of possible localized argyria after silver graft
implantation.
Report: Two patients presented with perigraft groin collections after implantation of silver grafts. During
reoperation, an ashen-grey necrotic substance was seen surrounding the grafts. The grafts were explanted and
lower limb perfusion restored. Cultures were negative and both patients had uneventful recoveries.
Discussion: Our cases are highly suggestive of a possible unique adverse effect: a combination of localized silver
toxicity and neutrophilic mediated tissue destruction.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Silver grafts have been developed to prevent graft in-
fections and have gradually found their way into the pre-
vention of vascular graft infection. Various studies have
shown the potential efﬁcacy of these grafts.1e3 No adverse
effects of silver vascular grafts have been reported. How-
ever, toxic effects of silver have been reported, and among
those, argyria, a grey discoloration of the skin, reported
with extensive and chronic use of silver. This report presents
two unique cases in whom localized argyria caused by
implanted silver grafts may have occurred.
CASE 1
In 2011, a 70-year-old male with a history of cutaneous
systemic lupus erythematosus was treated for lower limb
claudication related to an occlusion of the left common iliac
artery, receiving an iliofemoral silver graft (B. Braun Mel-
sungen AG, Germany). The procedure was complicated by a
bowel perforation caused by a drain for which a small
segment of small bowel was resected. Ten months later, in
January 2012, the patient presented with a collection of the
left groin. During surgical exploration, an ashen-grey
necrotic substance was seen around the full length of the
graft. The anastomosis was intact. After thorough debride-
ment, the wound was ﬁlled with gentamycin-impregnated
sponges (Garacol, EUSA Pharma, Oxford, UK) and the
prosthetic graft was kept in place. Pathological analysis
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in multinucleated giant cells (Fig. 1). There were three
reoccurrences before the patient was referred to our
department. No clinical symptoms of infection were pre-
sent, laboratory parameters were as follows: C-reactive
protein 5 mg/L; erythrocyte sedimentation rate of 23 mm
after 1 hour; white blood cell count:7*109/L. All cultures
proved negative. A ﬂuorodeoxyglucose positron-emission
tomography-computed tomography (FDG PET-CT) fusion
scan showed a diffuse inﬂammation with an intense path-
ological FDG uptake of all of the graft, highly suspicious of a
graft infection (Fig. 1B, C). Because of the relatively mild
infectious parameters, the dermatologist was consulted to
exclude an allergic reaction to silver. Cutaneous allergic
tests all proved negative. Consequently, the patient was
scheduled for graft excision. The same ashen-grey necrotic
material was found surrounding the silver graft. Extensive
specimen bacteriologic culture and debridement were
performed and the graft was excised. Lower limb perfusion
was restored using a reversed greater saphenous vein
bypass. The operation was uncomplicated. All cultures,
including sonication of the graft, proved negative. No
recurrence occurred after a follow-up of 12 months. Anti-
biotic treatment was stopped 3 months after graft excision.CASE 2
In 2011, a 67-year-old patient with a history of myocardial
infarction, coronary artery bypass graft and chronic
obstructive pulmonary disorder (GOLD 1) received an aorto-
bifemoral silver graft (B. Braun Melsungen AG, Germany)
because of an asymptomatic infrarenal abdominal aortic
aneurysm associated with bilateral common iliac artery
occlusions. Fourteen months later, the patient presented
with a bilateral groin collection. During surgical exploration,
Figure 1. (A) Histology of Patient A, showing a chronic inﬂammatory reaction and foreign bodies partially in multinucleated giant cells. (B)
PET-scan imaging of Patient A, showing increased uptake in the aorto-femoral bypass on the left side. (C) PET-CT fusion image of Patient A.
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anastomoses were intact. After debridement and ﬁlling of
the wound with gentamycin-impregnated sponges, the pa-
tient was referred to our department. Intraoperative cul-
tures were negative. Pathological analysis showed a
granulomatous inﬂammation with multiple histiocytes,
neutrophilic granulocytes, and multinucleated giant cells,
with an evident foreign body tissue reaction. Multiple black
foreign body scales were seen, mostly incorporated in the
giant cells (Fig. 2A). On presentation laboratory parameters
were: C-reactive protein 25 mg/L; erythrocyte sedimenta-
tion rate of 28 mm after 1 hour; white blood cell count
9.3*109/L. The FDG PET-CT fusion scan showed an intensepathological FDG uptake of all the graft, with a partial
ureteral obstruction suggesting a graft infection (Fig. 2A, B).
Cutaneous testing for silver proved negative. The patient
was scheduled for graft excision and in situ reconstruction.
Preoperatively, double J stents were placed in both ureters.
During surgery, the femoral extremities of both limbs were
free of tissue ingrowth and an ashen-grey necrotic sub-
stance was found to completely surround both limbs. The
graft was explanted after debridement. The femoral anas-
tomotic sites were closed by venous patches and a
rifampicin-impregnated polyester bifurcated graft was
anastomosed to the external iliac arteries. The patient was
discharged after 1 week. All cultures, including sonication of
Figure 2. (A) Histology of Patient B, showing a chronic inﬂammatory reaction and foreign bodies mostly in multinucleated giant cells. (B)
PET-scan imaging of Patient B, showing increased uptake in the aorto bi-femoral bypass. (C) PET-CT fusion image of Patient B.
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stopped 3 months after graft excision. The double J stents
were removed after 6 weeks by our urologist, after which
no further treatment was required. At 12-month follow-up,
the patient is doing well with no sign of infection.DISCUSSION
Silver is a rare element that exists in the environment. It has
bactericidal properties and is used in a variety of medical
applications. Metallic silver, for example, is used in ortho-
paedic prosthesis and heart valves, and soluble silver
components are used in a variety of topical agents andtablets. Traditionally, aortic graft infections have been
treated by an extensive debridement and extra-anatomic
reconstruction, but reinfection rates and disappointing
patency rates have led to the development of in situ
reconstruction options.4 Various options of applying anti-
microbial agents on commercially available in situ grafts
have been explored. Silver-coated grafts are commercially
available grafts that combine the advantage of being “off-
the-shelf” with the bactericidal effects of silver and are
designed for infection prevention.2,4,5 There are two com-
mercial silver grafts available. The main difference between
these grafts is the way silver is bonded to the graft. In the
ﬁrst (InterGard silver polyester graft, Maquet SARL, La
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is used to coat the graft. As the collagen link dissolves
within a few weeks, so will the silver ions and their
bactericidal effects. Long-term results of the InterGard silver
graft have not shown any toxic side effects from silver.2 The
other silver graft (B. Braun silver graft, Melsungen AG,
Germany) used in these patients has a different structure
with a metallic silver layer covering the graft. Therefore, the
silver will not dissolve; after 1 year, almost 98% is still linked
to the graft. Toxic effects have not been reported from the
B. Braun silver graft.6 The elemental difference in how silver
is bonded determines how both grafts can be used. The
InterGard silver graft offers only a temporary antimicrobial
activity for prophylactic use during the postoperative
period. The B. Braun silver graft, on the other hand, offers a
more or less permanent antimicrobial activity.
Review of the literature reveals silver to be a relatively
safe element. Rare toxic effects have been described only
with chronic exposure, most commonly as some kind of
argyria deﬁned as a local or generalized silver toxicity in
which a permanent ashen-grey discoloration of the skin oc-
curs caused by deposition of silver and a silver induced in-
crease in melanin complexes. Argyria has been reported from
the use of silver-containing medications and dental mate-
rials.7 In all these reports of argyria, silver-containing agents
were used extensively and over a long period of time.8 The
exact levels in which silver causes toxic effects are unknown
and are thought to vary with dose, duration, and route of
exposure, together with patient characteristics.9 Although
most of the symptoms presented by both of our cases may
be explained by a low-grade graft infection, low-grade in-
fections generally do not cause grey discoloration and tissue
necrosis. The observed ashen-grey necrotic material, sur-
rounding the full length of the grafts of both of our patients
strongly resembles the colour of patients with systemic
argyria and may be caused by a local silver overdose. Finally,
histologically, we found a chronic foreign tissue reaction in
which black particles (silver?) were found inside giant cells.
As the function of giant cells is to remove foreign bodies, no
such particles are found inside giant cells in the case of an
infection. The B Braun silver graft, used in both cases, has a
permanent silver layer covering the graft, which generates
silver ions over a prolonged timespan. It is therefore likely
that this necrotic material is caused by a combination be-
tween neutrophilic mediated tissue destruction and local
toxicity of silver caused by prolonged exposure or local
degradation of the graft. In their report, Tautenhahn et al.
demonstrated that silver-coated vascular polyester grafts
highly activate human neutrophils when compared with
regular polyester grafts, causing the neutrophil to release
high levels of elastase (a very destructive enzyme) in the
absence of a bacterial trigger.10 On the contrary, Jeanmonod
et al.11 provide evidence in vivo that silver acetate (used in
the Maquet graft), does not induce a leukocyte-mediated
tissue inﬂammatory response, but in fact stimulates
ingrowth of microvessels, promoting implant incorporation.
While the symptoms of both our cases have led to a
reoperation, we do not believe the localized argyria by itselfto be a dangerous entity. If both our cases really are a form
of localized argyria, graft excision would probably not have
been necessary. However, both patients presented with
suspected groin abscesses and, left untreated, these lumps
would have been very unlikely to resolve by themselves (as
demonstrated by our ﬁrst case in which local treatment
failed four times).
This is the ﬁrst report of localized argyria caused by
metallic silver-coated grafts. The observed greyish material
and the histology ﬁndings are highly indicative of argyria
and seem to exclude the possibility of a low-grade infection
of the graft.FUNDING
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